EOFY SALE: iBOTTLE+ NOW $199 — WAS $399. Ends June 30 · 30-day risk-free trial · Free shipping

Our Services

Web Design

Your content goes here. Edit or remove this text inline.

Logo Design

Your content goes here. Edit or remove this text inline.

Web Development

Your content goes here. Edit or remove this text inline.

VIEW ALL SERVICES

Shop Our Products

Hoodies

Your content goes here. Edit or remove this text inline.

T-Shirts

Your content goes here. Edit or remove this text inline.

Jeans

Your content goes here. Edit or remove this text inline.

BROWSE ALL OUR PRODUCTS

More of us

Customer Reviews

Your content goes here. Edit or remove this text inline.

Good Stuff We do!

Your content goes here. Edit or remove this text inline.

More From Us...

Your content goes here. Edit or remove this text inline.

EXPLORE CUSTOMERS STORIES

Discussion – 

0

Discussion – 

0

Homogeneous Carbon/Potassium-Incorporation Strategy for Synthesizing Red Polymeric Carbon Nitride Capable of Near-Infrared Photocatalytic H2 Production


Hydrogen Water Studies

CancerNovel Therapy

Homogeneous Carbon/Potassium-Incorporation Strategy for Synthesizing Red Polymeric Carbon Nitride Capable of Near-Infrared Photocatalytic H2 Production

by Lingting Zeng, Qianjun He, Chenliang Su, Mingjian Fan, Qinghua Xu, Wenjuan Yang, Xiao Wu, Yangsen Xu, Yonghao Xiao

Abstract:

The efficient utilization of near-infrared (NIR) light for photocatalytic hydrogen generation is vitally important to both solar hydrogen energy and hydrogen medicine, but remains a challenge at present, owing to the strict requirement of the semiconductor for high NIR responsiveness, narrow bandgap, and suitable redox potentials. Here, an NIR-active carbon/potassium-doped red polymeric carbon nitride (RPCN) is achieved for by using a similar-structure dopant as the melamine (C3H6N6) precursor with the solid KCl. The homogeneous and high incorporation of carbon and potassium remarkably narrows the bandgap of carbon nitride (1.7 eV) and endows RPCN with a high NIR-photocatalytic activity for H2 evolution from water at the rate of 140 µmol h−1 g−1 under NIR irradiation (700 nm ≤ λ ≤ 780 nm), and the apparent quantum efficiency is high as 0.84% at 700 ± 10 nm (and 13% at 500 ± 10 nm). A proof-of-concept experiment on a tumor-bearing mouse model verifies RPCN as being capable of intratumoral NIR-photocatalytic hydrogen generation and simultaneous glutathione deprivation for safe and high-efficacy drug-free cancer therapy. The results shed light on designing efficient photocatalysts to capture the full spectrum of solar energy, and also pioneer a new pathway to develop NIR photocatalysts for hydrogen therapy of major diseases.

Read more:

https://doi.org/10.1002/adma.202101455

Related Articles:

Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy

The poor penetration of nanocarriers within tumor dense extracellular matrices (ECM) greatly restricts the access of anticancer drugs to the deep tumor cells, resulting in low therapeutic efficacy. Moreover, the high toxicity of the traditional chemotherapeutics inevitably causes undesirable side…

Year Published: 2023Whole BodyCancer

Hydrogen inhalation enhances autophagy via the AMPK/mTOR pathway, thereby attenuating doxorubicin-induced cardiac…

Aims: Doxorubicin is a drug widely used in clinical cancer treatment, but severe cardiotoxicity limits its clinical application. Autophagy disorder is an important factor in the mechanism of doxorubicin-induced cardiac injury. As the smallest molecule in nature, hydrogen has various…

Year Published: 2023HeartCancer

Hydrogen nanobubbles: A novel approach toward radio-sensitization agents

Background: Ocular melanoma is a rare kind of eye malignancy that threatens the patient’s eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 (106 Ru) ophthalmic plaques…

Year Published: 2023EyeCancer

A drug co-delivery platform made of magnesium-based micromotors enhances combination therapy for…

Combination therapy is an emerging strategy to overcome multidrug resistance (MDR) in hepatocellular carcinoma (HCC) chemotherapy treatment. However, the passive diffusion in traditional delivery systems greatly retards the approach and penetration of drugs into hepatocellular carcinoma cells and thus hinders…

Year Published: 2023LiverCancer

NIR-Activatable Heterostructured Nanoadjuvant Cop/Nicop Executing Lactate Metabolism Interventions for Boosted Photocatalytic Hydrogen…

Near-infrared (NIR) laser-induced photoimmunotherapy has aroused great interest due to its intrinsic non-invasiveness and spatiotemporal precision, while immune evasion evoked by lactic acid (LA) accumulation severely limits its clinical outcomes. Although several metabolic interventions have been devoted to ameliorate immunosuppression,…

Year Published: 2023Whole BodyImmune Regulation

Hydrogen-rich water exerts anti-tumor effects comparable to 5-fluorouracil in a colorectal cancer…

Background: Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the world. Tumor removal remains the preferred frontline treatment; however, effective non-surgical interventions remain a high priority. 5-fluorouracil (5-FU) is a widely used chemotherapy agent, and molecular…

Year Published: 2022IntestineCancer

Sam Solomon

Research Scientist at iBottle

0 Comments

Submit a Comment

My cart
Your cart is empty.

Looks like you haven't made a choice yet.